EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications.
The last earnings update was 196 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
EOS imaging. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
EOS imaging's earnings available for a low price, and how does
this compare to other companies in the same industry?
EOS imaging is not considered high growth as it is expected to be loss making for the next 1-3 years.
EOS imaging's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
EOS imaging's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Mike Lobinsky is Chief Executive Officer of EOS imaging SA since January 1, 2019 and serves as its Director. He was President of North America at EOS imaging SA since joining in August 2017 until December 31, 2018. He has over twenty years’ experience in the medtech industry with senior management roles in sales, marketing, operations and business development in the fields of Orthopedic Robotics, Navigation, Imaging and Implants. He served as Vice President of Sales of Blue Belt Technologies, Inc. Mr. Lobinsky served as Vice President of Sales for East Region at Blue Belt Technologies, Inc. since February 2013. Mr. Lobinsky has over 16 years of experience in the medical device industry. He is experienced in building and managing successful sales, marketing and clinical organizations and in the market development of new and innovative products. He served as Vice President of Sales and Marketing at Biomedix Inc. Mr. Lobinsky was responsible for building and directing a national sales force who use consultative selling skills to help healthcare providers build vascular centers of excellence for Biomedix Inc. He designs and implements systems which ensure that there is alignment between company and sales professionals goals. Mr. Lobinsky held Director level sales management positions in the fields of Orthopedics, Neurosurgery, and Medical Imaging. He served as Regional Sales Manager of Stryker Corporation. He has held leadership positions at Smith and Nephew, Brainlab, Mr. Lobinsky received a BA from University of Wisconsin-River Falls.
Insufficient data for Mike to compare compensation growth.
Insufficient data for Mike to establish whether their remuneration is reasonable compared to companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure
Average tenure of the
management team in years:
The average tenure for the EOS imaging management team is less than 2 years, this suggests a new team.
CEO & Director
Chief Financial Officer
Chief Operating Officer
Vice President of Global Marketing
Director of Human Resources
Chief Medical Officer
Vice President of Engineering
Field Maintenance Director
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the EOS imaging board of directors is about average.
Board of Directors
Chairman of the Board
CEO & Director
Who owns this company?
Recent Insider Trading
More shares have been bought than sold by EOS imaging individual insiders in the past 3 months.
EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging system that provides low dose, full body, and stereo-radiographic images of patient in a functional position; EOSedge, an X-ray system that provides images quality for patients; sterEOS, a 3D modeling workstation that analyzes frontal and lateral EOS images which are captured simultaneously and registered to generate precise, patient-specific, and 3D models of the spine and/or lower limbs from weight-bearing, low dose, or Micro Dose EOS exams; and EOSapps, an online 3D surgical planning solutions based on unbiased, weight-bearing EOS images, and an accurate 2D/3D patient-specific data set. The company also provides 3D surgical planning software and patient-specific instruments for hip and knee arthroplasties. It sells its products in Europe, the Middle East, Africa, North Africa, and the Asia-Pacific. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS imaging SA was founded in 1989 and is headquartered in Paris, France.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.